History | Foslevodopa–foscarbidopa for treating advanced Parkinson’s with motor symptoms | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 178 KB)

Published:

26 October 2023
Register of interests (PDF 159 KB)

Published:

29 November 2023

Final draft guidance

Final draft guidance
Final draft guidance (PDF 335 KB)

Published:

26 October 2023
Committee papers (PDF 1.97 MB)

Published:

26 October 2023
Public committee slides (PDF 793 KB)

Published:

26 October 2023

Draft guidance

Draft guidance
Appraisal consultation document (PDF version) (PDF 375 KB)

Published:

31 May 2023
Appraisal consultation document (online commenting)
Committee papers (PDF 4.94 MB)

Published:

31 May 2023
Public committee slides (PDF 1.34 MB)

Published:

31 May 2023

Invitation to participate

Final scope (PDF 242 KB)

Published:

07 April 2022
Final stakeholder list (PDF 164 KB)

Published:

07 April 2022
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 366 KB)

Published:

07 April 2022
Equality impact assessment (Scoping) (PDF 137 KB)

Published:

07 April 2022

Scoping workshop

Draft scope post referral (PDF 245 KB)

Published:

02 March 2021
Draft matrix post referral (PDF 166 KB)

Published:

02 March 2021

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 245 KB)

Published:

02 March 2021
Draft matrix of consultees and commentators post referral (PDF 166 KB)

Published:

02 March 2021